NEWS
AIM Photonics: Enabling Quantum Leaps in PIC Technology
Photonic integrated circuits (PICs) are at the core of modern communications, powering everything from 5G networks to AI data centers. This article explores how AIM Photonics has strengthened U.S. manufacturing by creating an accessible, low-cost multi-project wafer (MPW) platform that accelerates innovation from design to production.
SiPhox Health: Where Integrated Photonics Meets Personal Wellness
In the latest episode of Photonics in Focus, Sarat Gundavarapu of SiPhox Health discusses the development of SiPhox Home, an innovative in-home diagnostic platform powered by photonic chips. The conversation explores how collaboration with AIM Photonics supported the advancement of this breakthrough technology—from early design challenges to scalable manufacturing solutions.
Adjacent Funding: Extending AIM Photonics’ Impact
Strategic financial support—whether awarded directly to AIM Photonics or to partners working in collaboration—enables the Institute to contribute to high-impact research that pushes the boundaries of integrated photonics.
Photonics Skills Gap Threatens Innovation in Quantum and AI
As industries from quantum computing to AI and advanced manufacturing increasingly depend on photonics, the field faces a critical obstacle: a shortage of skilled professionals. This article examines how the growing workforce gap is slowing progress in developing quantum computers, high-speed data centers and other technologies that rely on integrated photonics.
Phlotonics Receives $1.1M Award to Adapt BioproSense™ Platform for Regenerative Medicine
Collaboration through AIM Photonics’ BioINSPECT program—a joint initiative between AIM Photonics and Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA—is helping drive new advances in regenerative medicine. Under the program, AIM Photonics member Phlotonics Inc. has been awarded a $1.1M contract to work with leading academic researchers from the University of Rochester and Rochester Institute of Technology to adapt its BioproSense™ platform for regenerative biomanufacturing.